Epitomics

Epitomics is an emerging biotechnology company dedicated to developing breakthrough monoclonal antibody technologies for research and diagnostic applications. The company utilizes its unique patented RabMAb (rabbit monoclonal antibody) technology to generate antibodies with excellent binding affinity, specificity, and bioactivity both in vitro and in vivo. Epitomics is headquartered in Burlingame, California, with wholly-owned subsidiaries in Hong Kong and Hangzhou, China.